- Lead Products
- Early Stage Products
- Intellectual Property
- Press Room
- Contact Us
Foamix Announces Completion of Enrollment in Phase 2 Clinical Trial of Minocycline Foam (FMX103) for Treatment of Papulopustular RosaceaRead more...
Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for Tuesday, May 10Read more...
Foamix to Present Corporate Overview at the Barclays Global Healthcare ConferenceRead more...